DSS INC (DSS)

US26253C2017 - Common Stock

1.41  +0.03 (+2.17%)

Fundamental Rating

1

Overall DSS gets a fundamental rating of 1 out of 10. We evaluated DSS against 83 industry peers in the Commercial Services & Supplies industry. DSS may be in some trouble as it scores bad on both profitability and health. DSS has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

In the past year DSS has reported negative net income.
In the past year DSS has reported a negative cash flow from operations.
In the past 5 years DSS reported 4 times negative net income.
DSS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

DSS has a Return On Assets of -30.05%. This is amonst the worse of the industry: DSS underperforms 90.36% of its industry peers.
DSS has a Return On Equity of -78.66%. This is amonst the worse of the industry: DSS underperforms 80.72% of its industry peers.
Industry RankSector Rank
ROA -30.05%
ROE -78.66%
ROIC N/A
ROA(3y)-29.46%
ROA(5y)-20.13%
ROE(3y)-64.74%
ROE(5y)-43.02%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DSS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

DSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DSS has more shares outstanding
DSS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DSS is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -2.72, we must say that DSS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DSS (-2.72) is worse than 90.36% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that DSS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.13, DSS is in the better half of the industry, outperforming 74.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -2.72
ROIC/WACCN/A
WACC8.04%

2.3 Liquidity

A Current Ratio of 1.17 indicates that DSS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.17, DSS is doing worse than 72.29% of the companies in the same industry.
DSS has a Quick Ratio of 1.11. This is a normal value and indicates that DSS is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.11, DSS is not doing good in the industry: 63.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.11

2

3. Growth

3.1 Past

DSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.96%, which is quite impressive.
DSS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.43%.
DSS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.32% yearly.
EPS 1Y (TTM)53.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.75%
Revenue 1Y (TTM)-54.43%
Revenue growth 3Y25.34%
Revenue growth 5Y10.32%
Sales Q2Q%-41.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

DSS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 139.60, the valuation of DSS can be described as expensive.
DSS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. DSS is more expensive than 65.06% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.22. DSS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 139.6

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DSS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DSS INC

NYSEARCA:DSS (9/6/2024, 8:09:04 PM)

1.41

+0.03 (+2.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.97M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 139.6
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.05%
ROE -78.66%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.17
Quick Ratio 1.11
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)53.96%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y100.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-54.43%
Revenue growth 3Y25.34%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y